Apnimed

APMD · NASDAQ

$18.51+$1.92 (+11.54%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $16.60

APMD analyst rating

BuyConsensus of 4 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy4
Hold0
Underperform0
Sell0

12-month price target · 5 analysts

Average $51.34 (+177.4% upside)

Low: $41.41
Now: $18.51
High: $63.00

Upgrades and downgrades

The latest rating actions, newest first

APMD analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
LifeSci Capital	Aug 25, 2026	Initiates	Outperform	$50.00	35%
Cantor Fitzgerald	Aug 25, 2026	Initiates	Overweight	$60.00	49%
Evercore ISI Group	Aug 25, 2026	Initiates	Outperform	—	53%
B of A Securities	Aug 25, 2026	Initiates	Buy	$41.00	56%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.